These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6270012)

  • 1. EBV infection of mitogen-stimulated human B lymphocytes.
    Einhorn L; Klein E
    Int J Cancer; 1981 Feb; 27(2):181-3. PubMed ID: 6270012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of EBNA precedes the first cellular S-phase after EBV-infection of human lymphocytes.
    Einhorn L; Ernberg I
    Int J Cancer; 1978 Feb; 21(2):157-60. PubMed ID: 203544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the transformation of human lymphocytes by Epstein-Barr virus. I. Sequential occurrence from the virus-determined nuclear antigen synthesis, to blastogenesis, to DNA synthesis.
    Takada K; Osato T
    Intervirology; 1979; 11(1):30-9. PubMed ID: 218892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous detection of the two main proliferation driving EBV encoded proteins, EBNA-2 and LMP-1 in single B cells.
    Rasul AE; Nagy N; Sohlberg E; Ádori M; Claesson HE; Klein G; Klein E
    J Immunol Methods; 2012 Nov; 385(1-2):60-70. PubMed ID: 22921685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human B lymphocytes activated by Epstein-Barr virus (EBV) or by mitogens suppress mitogen-induced immunoglobulin production.
    Tsukuda K; Berczi I; Klein G
    J Immunol; 1981 May; 126(5):1810-3. PubMed ID: 6260858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphoblastoid transformation and kinetics of appearance of viral nuclear antigen (EBNA) in cord-blood lymphocytes infected by Epstein-Barr Virus (EBV).
    Yata J; Desgranges C; Nakagawa T; Favre MC; De-The G
    Int J Cancer; 1975 Mar; 15(3):377-84. PubMed ID: 49325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus susceptibility of normal human B lymphocyte populations.
    Aman P; Ehlin-Henriksson B; Klein G
    J Exp Med; 1984 Jan; 159(1):208-20. PubMed ID: 6319530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early events in Epstein-Barr virus infection provide a model for B cell activation.
    Thorley-Lawson DA; Mann KP
    J Exp Med; 1985 Jul; 162(1):45-59. PubMed ID: 2989413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resting B-cells, EBV-infected B-blasts and established lymphoblastoid cell lines differ in their Rb, p53 and EBNA-5 expression patterns.
    Szekely L; Pokrovskaja K; Jiang WQ; Selivanova G; Löwbeer M; Ringertz N; Wiman KG; Klein G
    Oncogene; 1995 May; 10(9):1869-74. PubMed ID: 7753563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on transformation of human lymphocytes by Epstein-Barr virus (author's transl)].
    Takada K
    Hokkaido Igaku Zasshi; 1980 Sep; 55(5):447-70. PubMed ID: 6263773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the transformation of human lymphocytes by Epstein-Barr virus. II. Abortive response of leukemic cells to the transforming virus.
    Takada K; Yamamoto K; Osato T
    Intervirology; 1980; 13(4):223-31. PubMed ID: 6248483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.
    Wang F; Gregory CD; Rowe M; Rickinson AB; Wang D; Birkenbach M; Kikutani H; Kishimoto T; Kieff E
    Proc Natl Acad Sci U S A; 1987 May; 84(10):3452-6. PubMed ID: 3033649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of polyamine synthesis in human B lymphocytes during primary infection with Epstein-Barr virus (EBV) blocks cellular DNA synthesis but not the expression of EBV-encoded nuclear antigens (EBNA).
    Aman P; Oredsson SM; Heby O
    Biochem Biophys Res Commun; 1989 Mar; 159(3):945-52. PubMed ID: 2539156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of Epstein-Barr virus transformation of human lymphocytes: susceptibility of B lymphocyte subpopulations and differentiation stage of the transformed cells].
    Koizumi S
    Hokkaido Igaku Zasshi; 1985 Sep; 60(5):724-34. PubMed ID: 3000906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus antibodies in patients with ataxia-telangiectasia and other immunodeficiency diseases.
    Joncas JH; Wills A; Reece E; Fox Z
    Can Med Assoc J; 1981 Oct; 125(8):845-9. PubMed ID: 6272957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoic acid and steroids inhibit Epstein-Barr virus-induced nuclear antigen, DNA synthesis and lymphocyte transformation.
    Sundar SK; Levine PH; Ablashi DV; Menezes J
    Anticancer Res; 1984; 4(6):415-8. PubMed ID: 6097161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simple assay method for susceptibility of human lymphocytes to Epstein-Barr virus infection.
    Takada K; Osato T
    Intervirology; 1982; 18(1-2):87-91. PubMed ID: 6288618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on Epstein-Barr virus (EBV) infection and reactivity of peripheral B lymphocytes to EBV in patients with ataxia telangiectasia].
    Okano M
    Hokkaido Igaku Zasshi; 1986 Jul; 61(4):584-92. PubMed ID: 3019855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 15-mediated induction of cytotoxic effector cells capable of eliminating Epstein-Barr virus-transformed/immortalized lymphocytes in culture.
    Sharif-Askari E; Fawaz LM; Tran P; Ahmad A; Menezes J
    J Natl Cancer Inst; 2001 Nov; 93(22):1724-32. PubMed ID: 11717333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of Epstein-Barr virus activation of human B lymphocytes.
    Bird AG; Britton S; Ernberg I; Nilsson K
    J Exp Med; 1981 Sep; 154(3):832-9. PubMed ID: 6268732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.